The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathologic characteristics and treatment outcomes of adenoid cystic carcinoma (ACC) by different primary sites.
 
Larissa Passarini
No Relationships to Disclose
 
Felippe Neto
No Relationships to Disclose
 
Vitor Cavalheiro
No Relationships to Disclose
 
Wesley Lima
No Relationships to Disclose
 
Lucas de Menezes
No Relationships to Disclose
 
Carlos Eduardo Brantis-de-Carvalho
No Relationships to Disclose
 
Renata Ferrarotto
Consulting or Advisory Role - Answers in CME; Bicara Therapeutics; Coherus Biosciences; Eisai; Johnson & Johnson/Janssen; Labcorp Drug Development; Pyxis; Raptor Pharmaceuticals; Regeneron; Rgenta
Research Funding - Avacta Life Sciences (Inst); Bicara Therapeutics (Inst); Gilead Sciences (Inst); ISA Pharmaceuticals (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst); Remix Therapeutics (Inst); Rgenta (Inst); Seagen (Inst); Viracta Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties on UpToDate chapter on olfactory neuroblastoma, ~ 300 dollars per year
Travel, Accommodations, Expenses - Bicara Therapeutics
 
Gilberto Castro
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen; Libbs; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Takeda; Yuhan
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Milena Mak
Honoraria - Bristol-Myers Squibb; Johnson & Johnson/Janssen; Lilly; Merck KGaA; Sanofi; United Medical
Travel, Accommodations, Expenses - Knight Pharmaceuticals